Reviewing Pheton (NASDAQ:PTHL) & Health In Tech (NASDAQ:HIT)

Health In Tech (NASDAQ:HIT) and Pheton (NASDAQ:PTHL) are both small-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, dividends, risk, valuation, profitability and analyst recommendations.

Analyst Recommendations

This is a summary of recent ratings and recommmendations for Health In Tech and Pheton, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Health In Tech	1	0	1	1	2.67
Pheton	1	0	0	0	1.00

Health In Tech presently has a consensus target price of $3.50, suggesting a potential upside of 256.42%. Given Health In Tech’s stronger consensus rating and higher possible upside, equities analysts clearly believe Health In Tech is more favorable than Pheton.

Earnings & Valuation

This table compares Health In Tech and Pheton”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Health In Tech	$32.83 million	1.96	-$4.59 million	($0.07)	-14.03
Pheton	$305,215.00	6.29	-$660,000.00	N/A	N/A

Pheton has lower revenue, but higher earnings than Health In Tech.

Profitability

This table compares Health In Tech and Pheton’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Health In Tech	N/A	N/A	N/A
Pheton	N/A	N/A	N/A

Volatility and Risk

Health In Tech has a beta of 2.82, indicating that its stock price is 182% more volatile than the S&P 500. Comparatively, Pheton has a beta of 5.4, indicating that its stock price is 440% more volatile than the S&P 500.

Summary

Health In Tech beats Pheton on 5 of the 8 factors compared between the two stocks.

About Health In Tech

Health in Tech, Inc. engages in the provision of insurance technology platforms which offer a marketplace of processes in the healthcare industry. Its services include Stone Mountain Risk, eDIYBS, HI Card, HI Performance Network, and Ancillary Products. The company was founded by Tim Johnson in 2014 and is headquartered in Stuart, FL.

About Pheton

Pheton Holdings Ltd. operates as a holding company with interests in providing healthcare solutions. The firm through its subsidiaries engages in the development and commercialization of brachytherapy TPS specifically used for radioactive particle implantation, a type of radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. The company was founded in 1998 and is headquartered in Beijing, China.